Physicians weigh in on long-term use of IBD treatments

06/17/2013 | Gastroenterology & Endoscopy News

Patients with inflammatory bowel disease may want to discontinue treatment once they achieve remission but Dr. David Rubin of the Inflammatory Bowel Disease Center at the University of Chicago says it is important to remember IBD is a chronic disease and stopping therapy can lead to recurrence. Physicians say there are limited data on even de-escalating treatments. There may be some cases in which scaling back is appropriate, but the science is still emerging, Rubin and others said.

View Full Article in:

Gastroenterology & Endoscopy News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC